Evidence map›Paper›PMID 19950285›Full record

ArticleArthritis and rheumatism2009

A novel subpopulation of B-1 cells is enriched with autoreactivity in normal and lupus-prone mice.

Xuemei Zhong, Stanley Lau, Chunyan Bai, Nicolas Degauque, Nichol E Holodick, Scott J Steven, Joseph Tumang, Wenda Gao, Thomas L Rothstein

Open access · bronzeAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 70 citations in OpenAlex.

  1. B1 Cells for Life.Immunological reviews · 2026
    Review
  2. Distinct autoreactive CD19Nature communications · 2025
    Article
  3. Posttranscriptional control of the B cell receptor by HuR is essential for innate B cell maintenance and function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Homeostasis and regulation of autoreactive B cells.Cellular & molecular immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xuemei ZhongBoston University Medical Center, Boston, Massachusetts 02118, USA. xuemei.zhong@bmc.org
Stanley Lau
Chunyan Bai
Nicolas Degauque
Nichol E Holodick
Scott J Steven
Joseph Tumang
Wenda Gao
Thomas L Rothstein
Boston University · USBeth Israel Deaconess Medical Center · USBoston Medical Center · US

Funding

PHORBOL ESTER RESPONSIVE B LYMPHOCYTESR01AI029690 · NIAID · WESTERN MICHIGAN UNIV SCHOOL OF MEDICINE · PI ROTHSTEIN, THOMAS L · 1990 to 2019
$6.9M
REGULATION AND FUNCTION OF CYCLIN D3 IN B CELL SUBSETSP01AI060896 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ROTHSTEIN, THOMAS L · 2004 to 2008
$4.5M
Aberrant Signaling in B-1 CellsR56AI029690 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ROTHSTEIN, THOMAS L · 2008 to 2008
$414k
ABERRANT SIGNALING IN B1 CELLSR21AI029690 · NIAID · BOSTON MEDICAL CENTER · PI ROTHSTEIN, THOMAS L · 1997 to 1997
–
NIAID NIH HHS AI-029690NIAID NIH HHS AI-060896NIAID NIH HHS P01 AI060896NIAID NIH HHS R01 AI029690NIAID NIH HHS R56 AI029690
6 · The paper itself

Abstract

objectiveB-1 cells have long been suggested to play an important role in lupus. However, reports to date have been controversial regarding their pathogenic or protective roles in different animal models. We undertook this study to investigate a novel subpopulation of B-1 cells and its roles in murine lupus.

methodsLymphocyte phenotypes were assessed by flow cytometry. Autoantibody secretion was analyzed by enzyme-linked immunosorbent assay, autoantigen proteome array, and antinuclear antibody assay. Cell proliferation was measured by thymidine incorporation and 5,6-carboxyfluorescein succinimidyl ester dilution. B cell Ig isotype switching was measured by enzyme-linked immunospot assay.

resultsAnti-double-stranded DNA (anti-dsDNA) autoantibodies were preferentially secreted by a subpopulation of CD5+ B-1 cells that expressed programmed death ligand 2 (termed L2pB1 cells). A substantial proportion of hybridoma clones generated from L2pB1 cells reacted to dsDNA. Moreover, these clones were highly cross-reactive with other lupus-related autoantigens. L2pB1 cells were potent antigen-presenting cells and promoted Th17 cell differentiation in vitro. A dramatic increase of circulating L2pB1 cells in lupus-prone BXSB mice was correlated with elevated serum titers of anti-dsDNA antibodies. A significant number of L2pB1 cells preferentially switched to IgG1 and IgG2b when stimulated with interleukin-21.

conclusionOur findings identify a novel subpopulation of B-1 cells that is enriched for autoreactive specificities, undergoes isotype switch, manifests enhanced antigen presentation, promotes Th17 cell differentiation, and is preferentially associated with the development of lupus in a murine model. Together, these findings suggest that L2pB1 cells have the potential to initiate autoimmunity through serologic and T cell-mediated mechanisms.

Indexed as

AnimalsAntibodies, AntinuclearAutoimmunityB-LymphocytesCD5 AntigensCell ProliferationDisease Models, AnimalDNAHybridomasImmunoglobulin Class SwitchingImmunoglobulin GInterleukin-21InterleukinsLupus Erythematosus, SystemicMiceMice, Inbred BALB CAntibodies, AntinuclearCD5 AntigensDNAImmunoglobulin GInterleukin-21InterleukinsPdcd1lg2 protein, mousePeptidesProgrammed Cell Death 1 Ligand 2 Protein

Identifiers

PMID19950285
PMCPMC2868318
OpenAlexW1965418852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.